相关实验视频
Updated: Jun 28, 2026

08:25
Identification of Circular RNAs using RNA Sequencing
Published on: November 14, 2019
12.1K
可解释的多实例异构图网络学习建模CircRNA-药物敏感性关联预测预测
Mengting Niu1,2,3, Chunyu Wang4, Yaojia Chen1,5,6
1Institute of Fundamental and Frontier Sciences, University of Electronic Science and Technology of China, Chengdu, China.
BMC biology
|May 14, 2025
概括
预测药物敏感性与循环RNAs (circRNAs) 的关联对于个性化医学至关重要. 一种新的方法,MiGNN2CDS,利用多实例学习和图形网络来准确识别这些关键的circRNA药物关系.
科学领域:
- 生物信息学是一种生物信息学.
- 计算生物学 计算生物学
- 基因组学就是基因组学.
背景情况:
- 循环RNAs (circRNAs) 影响人类细胞中的药物敏感性,影响治疗结果.
- 鉴定circRNA与药物敏感性关联的传统实验方法是低效和昂贵的.
- 准确预测新型circRNA-药物敏感性关系对于推进个性化医学至关重要.
研究的目的:
- 开发一种有效的计算方法来预测circRNA-药物敏感性关联.
- 构建一个整合circRNA和药物特征的异质图形网络模型.
- 提高circRNA药物敏感性预测的准确性和可解释性.
主要方法:
- 使用circRNA特征,药物特征和药物结构信息构建了一个异质网络.
- 采用异质图卷积网络 (GCN) 进行深度特征嵌入.
- 集成的多实例学习 (MIL) 具有伪元路实例生成器和BiTrans用于元路级别的表示.
- 开发了一个可解释的多尺度注意力网络,用于最终的预测和分析.
主要成果:
- 与现有的最先进的方法相比,MiGNN2CDS模型显示出更高的预测准确性.
- 案例研究证实了该模型在预测以前未知的circRNA药物关联方面的能力.
- 通过高可信度元路径分析验证了模型的解释性.
结论:
- MiGNN2CDS提供了一种强大且可解释的方法来预测circRNA药物敏感性.
- 这些发现通过确定关键的circRNA生物标志物,有助于开发向疗法.
- 该研究为药物敏感性研究提供了有价值的计算工具,代码和数据公开可用.
相关概念视频
Quantitative Aspects of Drug-Receptor Interaction
The receptor occupancy theory connects a drug's response to the number of occupied receptors. With higher drug concentrations, more receptors are occupied, leading to increased responses. The formation of drug-receptor complexes involves association and dissociation rates, which reach equilibrium when the forward and backward reactions are equal. The equilibrium association constant (Ka) and its inverse, the equilibrium dissociation constant (Kd), indicate drug affinity. Higher Ka and lower Kd...
Pharmacogenomics: Identification of New Drug Targets
Advances in genomics have profoundly influenced drug discovery by increasing both the speed and accuracy of pharmaceutical development. Pharmacogenomics, which examines how genetic variation influences drug response, facilitates the identification of novel therapeutic targets and enables patient stratification for personalized treatment. These strategies contribute to improved drug efficacy, minimized adverse effects, and more efficient clinical trial design.Mapping genetic differences...

